Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by SteelPeak Wealth LLC

SteelPeak Wealth LLC grew its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 93.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 347,212 shares of the pharmacy operator’s stock after acquiring an additional 167,610 shares during the quarter. SteelPeak Wealth LLC’s holdings in Walgreens Boots Alliance were worth $7,531,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of WBA. Vanguard Group Inc. grew its stake in Walgreens Boots Alliance by 14.5% during the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after purchasing an additional 10,962,030 shares during the last quarter. Capital World Investors boosted its position in Walgreens Boots Alliance by 29.1% in the fourth quarter. Capital World Investors now owns 18,448,648 shares of the pharmacy operator’s stock valued at $481,694,000 after buying an additional 4,163,317 shares during the last quarter. Morgan Stanley increased its holdings in Walgreens Boots Alliance by 15.8% in the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after buying an additional 1,720,228 shares during the period. Norges Bank purchased a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $29,816,000. Finally, International Assets Investment Management LLC lifted its stake in Walgreens Boots Alliance by 1,985.1% during the 4th quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock valued at $23,226,000 after acquiring an additional 846,884 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 0.8 %

NASDAQ:WBA traded down $0.09 on Friday, hitting $12.10. The stock had a trading volume of 54,346,456 shares, compared to its average volume of 17,649,060. The company has a fifty day moving average price of $16.49 and a two-hundred day moving average price of $20.14. Walgreens Boots Alliance, Inc. has a 1-year low of $11.68 and a 1-year high of $31.32. The company has a quick ratio of 0.32, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. The stock has a market cap of $10.43 billion, a price-to-earnings ratio of -1.79, a PEG ratio of 0.84 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The business had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company’s revenue was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.00 earnings per share. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 2.94 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.27%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on WBA. UBS Group cut their price objective on shares of Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating on the stock in a research note on Monday, June 24th. Evercore ISI decreased their price objective on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a report on Friday. Truist Financial lowered their target price on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research note on Friday. Barclays reduced their price target on Walgreens Boots Alliance from $21.00 to $19.00 and set an “underweight” rating for the company in a research report on Monday, June 24th. Finally, SVB Leerink lowered their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research report on Monday, March 18th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $20.64.

Insider Activity

In related news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.